|
27
|
118
|
4q14A |
Crystal structure of 5-hydroxyisourate hydrolase from brucella melitensis |
|
28
|
116
|
4pvlA |
X-ray structure of human transthyretin (ttr) at room temperature to 1.9a resolution |
|
27
|
116
|
4pwgA |
Crystal structure of v30m mutant human transthyretin complexed with caffeic acid ethyl ester |
|
28
|
116
|
4pwhA |
Crystal structure of v30m mutant human transthyretin complexed with caffeic acid 1,1-dimethylallyl ester |
|
25
|
116
|
4pvmA |
Neutron structure of human transthyretin (ttr) at room temperature to 2.0a resolution (laue) |
|
29
|
116
|
4pwjA |
Crystal structure of v30m mutant human transthyretin complexed with nordihydroguaiaretic acid |
|
30
|
117
|
4pmfA |
Human transthyretin (ttr) complexed with curcumin |
|
28
|
116
|
4pwkA |
Crystal structure of v30m mutant human transthyretin complexed with dihydroguaiaretic acid |
|
28
|
115
|
4n85A |
Crystal structure of human transthyretin |
|
26
|
115
|
4n86A |
Crystal structure of human transthyretin complexed with glabridin |
|
25
|
115
|
4n87A |
Crystal structure of v30m mutant human transthyretin complexed with glabridin |
|
23
|
116
|
4mrbA |
Wild type human transthyretin ph 7.5 |
|
25
|
116
|
4mrcA |
Human transthyretin ser52pro mutant |
|
24
|
116
|
4masA |
High resolution structure of wild type human transthyretin in complex with 3,3',5,5'-tetrachloro-[1,1'-biphenyl]-4,4'diol |
|
28
|
116
|
4ky2A |
Transthyretin in complex with the fluorescent folding sensor (e)-7-hydroxy-3-(4-hydroxy-3,5-dimethylstyryl)-4-methyl-2h-chromen-2-one |
|
28
|
116
|
4l1sA |
Covalent modification of transthyretin k15 by yielding the fluorescent conjugate (e)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzamide |
|
29
|
116
|
4l1tA |
Transthyretin in complex with (e)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzoic acid |
|
26
|
116
|
4ikjA |
Crystal structure of wild-type human transthyretin in complex with sulindac |
|
23
|
116
|
4i89A |
Crystal structure of transthyretin in complex with diflunisal at acidic ph |
|
29
|
116
|
4iizA |
Crystal structure of wild-type human transthyretin in complex with lumiracoxib |
|
28
|
116
|
4ikkA |
Crystal structure of wild-type human transthyretin in complex with sulindac |
|
30
|
116
|
4ik6A |
Crystal structure of human transthyretin in complex with lumiracoxib |
|
26
|
116
|
4iklA |
Crystal structure of wild-type human transthyretin in complex with sulindac |
|
27
|
116
|
4i85A |
Crystal structure of transthyretin in complex with chf5074 at neutral ph |
|
29
|
116
|
4ikiA |
Crystal structure of wild-type human transthyretin in complex with indomethacin |
|
25
|
116
|
4i87A |
Crystal structure of ttr variant i84s in complex with chf5074 at acidic ph |
|
28
|
116
|
4ik7A |
Crystal structure of human transthyretin in complex with indomethacin |
|
29
|
116
|
4hjtA |
Kinetic stabilization of transthyretin through covalent modification of k15 by (e)-n-(4-(4-hydroxy-3,5-dimethylstyryl)phenyl)propionamide |
|
28
|
116
|
4hjuA |
Transthyretin in complex with (e)-n-(3-(4-hydroxy-3,5-dimethylstyryl)phenyl)acrylamide |
|
27
|
116
|
4hjsA |
Kinetic stabilization of transthyretin through covalent modification of k15 by (e)-n-(4-(4-hydroxy-3,5-dimethylstyryl)ethanesulfonamide |
|
25
|
116
|
4hiqA |
The structure of v122i mutant transthyretin in complex with ag10 |
|
26
|
115
|
4hisA |
The structure of v122i mutant transthyretin in complex with tafamidis |
|
27
|
116
|
4fi7A |
Kinetic stabilization of transthyretin through covalent modification of k15 by 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide |
|
28
|
116
|
4fi8A |
Kinetic stabilization of transthyretin through covalent modification of k15 by 4-bromo-3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide |
|
27
|
115
|
4fi6A |
Kinetic stabilization of transthyretin through covalent modification of k15 by 3-(5-(3,5-dichlorophenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide |
|
28
|
116
|
3qvaA |
Structure of klebsiella pneumoniae 5-hydroxyisourate hydrolase |
|
26
|
113
|
3q1eA |
Crystal structure of y116t/i16a double mutant of 5-hydroxyisourate hydrolase in complex with t4 |
|
27
|
116
|
3p3tA |
Human transthyretin (ttr) complexed with 4-(3-(2-flourophenoxy)propyl)-3,5-dimethyl-1h-pyrazole |
|
26
|
116
|
3ozkA |
Crystal structure of human transthyretin variant a25t in complex with thyroxine (t4) |
|
26
|
115
|
3p3sA |
Human transthyretin (ttr) complexed with (z)-5-(3,5-dibromo-4-hydroxybenzylidene)-imino-1-methylimidazolidin-4-one |
|
27
|
116
|
3p3rA |
Transthyretin in complex with (3,4-dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone |
|
28
|
116
|
3p3uA |
Human transthyretin (ttr) complexed with 5-(2-ethoxyphenyl)-3-(pyridin-4-yl)-1,2,4-oxadiazole |
|
25
|
116
|
3ozlA |
Crystal structure of human transthyretin variant a25t in complex with flufenamic acid. |
|
27
|
116
|
3neeA |
Wild type human transthyretin (ttr) complexed with gc-1 (ttrwt:gc-1) |
|
28
|
116
|
3neoA |
Wild type human transthyretin (ttr) complexed with gc-24 (ttrwt:gc-24) |
|
27
|
116
|
3nexA |
V30m mutant human transthyretin (ttr) complexed with gc-24 (v30m:gc-24) |
|
27
|
117
|
3ng5A |
Crystal structure of v30m transthyretin complexed with (-)-epigallocatechin gallate (egcg) |
|
27
|
116
|
3nesA |
V30m mutant human transthyretin (ttr) complexed with gc-1 (v30m:gc-1) |
|
27
|
115
|
3m1oA |
Human transthyretin (ttr) complexed with 2-((3,5-dichloro-4-hydroxyphenyl)amino)benzoic acid |
|
27
|
115
|
3kguA |
Wild type human transthyretin (ttr) complexed with genistein (ttrwt:gen) ph 7.5 |
